We present a case of renal metanephric adenoma (MA) mimicking papillary renal cell carcinoma (PRCC) on computed tomography (CT). In the present case, double-phase enhanced CT showed a hypovascular right renal tumor with gradual and prolonged enhancement. The renal tumor was surgically removed. Histological examination of the resected specimen showed renal MA. Although the radiological features of renal MA have been described by some authors, only a few reports have mentioned the pattern of enhancement on multiphase enhanced CT. The pattern of enhancement of a renal tumor is likely to be correlated with its pathological features. Since renal MA is thought to be genetically related to PRCC, these two tumors are likely to demonstrate similar radiological features, so that differentiating between them becomes difficult. In patients with a hypovascular renal mass that shows gradual and prolonged enhancement on multiphase enhanced CT, the diagnosis of renal MA should be considered.

Keywords:
Renal metanephric adenoma, Papillary renal cell carcinoma, Computed tomography
1.
Jinzaki M, Tanimoto A, Mukai M, Ikeda E, Kobayashi S, Yuasa Y, Narimatsu Y, Murai M: Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000;24:835-842.
2.
Amin MB, Amin MB, Tamboli P, Javaidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon M: Prognostic impact of histologic subtyping of adult renal epithelial neoplasms. Am J Surg Pathol 2002;26:281-291.
3.
Davis CJ, Barton JH, Sesterhenn IA, Mostofi FK: Metanephric adenoma: clinicopathological study of fifty patients. Am J Surg Pathol 1995;19:1101-1114.
4.
Yoshioka K, Miyakawa A, Ohno Y, Namiki K, Horiguchi Y, Murai M, Mukai M, Tachibana M: Production of erythropoietin and multiple cytokines by metanephric adenoma results in erythrocytosis. Pathol Int 2007;57:529-536.
5.
Araki T, Hata H, Asakawa E, Araki T: MRI of metanephric adenoma. J Comput Assist Tomogr 1998;22:87-90.
6.
Hwang SS, Choi YJ: Metanephric adenoma of the kidney: case report. Abdom Imaging 2004;29:309-311.
7.
Zhang LJ, Yang GF, Lu GM: CT and ultrasound findings of metanephric adenoma: a report of two cases and literature review. Br J Radiol 2011;84:e51-e54.
8.
Brown JA, Anderi KL, Borell TJ, Qian J, Bostwick DG, Jenkins RB: Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. J Urol 1997;158:370-374.
9.
Tickoo SK, Reuter VE, Amin MB, Srigley JR, Epstein JI, Min KW, Rubin MA, Ro JY: Renal oncocytosis: a morphologic study of fourteen cases. Am J Surg Pathol 1999;23:1094-1101.
10.
Kuroda N, Toi M, Hiroi M, Enzan H: Review of papillary renal cell carcinoma with focus on clinical and pathological aspects. Histol Histopathol 2003;18:487-497.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.